JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on February 11, 2003; DOI: 10.1124/jpet.102.048090

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.102.048090v1
305/2/703    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anakk, S.
Right arrow Articles by Strobel, H. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anakk, S.
Right arrow Articles by Strobel, H. W.

Vol. 305, Issue 2, 703-709, May 2003

Insights into Gender Bias: Rat Cytochrome P450 3A9

Sayeepriyadarshini Anakk, Chun Ying Ku, Mary Vore and Henry W. Strobel

Department of Biochemistry and Molecular Biology, University of Texas Medical School, Houston, Texas (S.A., C.Y.K, H.W.S.); and Graduate Center for Toxicology, Chandler Medical Center, University of Kentucky, Lexington, Kentucky (M.V.)

Some members of the CYP3A subfamily show gender-dependent expression. Using quantitative real-time polymerase chain reaction, we report that female rats have 28-fold higher CYP3A9 mRNA levels than males in liver and 3.8-fold higher in lung. Furthermore, the CYP3A9 expression profile in kidney exhibits a regio-specific distribution, i.e., a 10-fold higher expression in cortex compared with medulla. Also, we observed tissue-specific estrogen regulation of the CYP3A9 message. Estrogen treatment caused a significant up-regulation in liver and a marked down-regulation both in the cortex and medulla of the kidney. Upon ovariectomy, hepatic and brain CYP3A9 expression were reduced significantly, but a modest increase in kidney expression was observed. The effects of ovariectomy on CYP3A9 gene expression were reversed upon exogenous estrogen treatment. CYP3A protein levels and hepatic microsomal activity toward benzphetamine after various treatments showed changes parallel to CYP3A9 mRNA levels. We report for the first time that CYP3A9 levels change dramatically during the course of pregnancy.

0022-3565/03/3052-0703$07.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2003 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Toxicol SciHome page
N. Kiyosawa, J. C. Kwekel, L. D. Burgoon, K. J. Williams, C. Tashiro, B. Chittim, and T. R. Zacharewski
o,p'-DDT Elicits PXR/CAR-, Not ER-, Mediated Responses in the Immature Ovariectomized Rat Liver
Toxicol. Sci., February 1, 2008; 101(2): 350 - 363.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
S. Anakk, W. Huang, J. L. Staudinger, K. Tan, T. J. Cole, D. D. Moore, and H. W. Strobel
Gender Dictates the Nuclear Receptor-Mediated Regulation of CYP3A44
Drug Metab. Dispos., January 1, 2007; 35(1): 36 - 42.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
E. T. Williams, M. Leyk, S. A. Wrighton, P. J. A. Davies, D. S. Loose, G. L. Shipley, and H. W. Strobel
Estrogen Regulation of the Cytochrome P450 3A Subfamily in Humans
J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 728 - 735.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
S. Nisar, C. S. Lane, A. F. Wilderspin, K. J. Welham, W. J. Griffiths, and L. H. Patterson
A PROTEOMIC APPROACH TO THE IDENTIFICATION OF CYTOCHROME P450 ISOFORMS IN MALE AND FEMALE RAT LIVER BY NANOSCALE LIQUID CHROMATOGRAPHY-ELECTROSPRAY IONIZATION-TANDEM MASS SPECTROMETRY
Drug Metab. Dispos., April 1, 2004; 32(4): 382 - 386.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
W. Zhang, A. F. Purchio, R. Coffee, and D. B. West
DIFFERENTIAL REGULATION OF THE HUMAN CYP3A4 PROMOTER IN TRANSGENIC MICE AND RATS
Drug Metab. Dispos., February 1, 2004; 32(2): 163 - 167.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.